Audiology Services via Telehealth for Hearing Loss in Aging
Trial Summary
What is the purpose of this trial?
The ACHIEVE Hearing Intervention Follow-Up study is a randomized trial of a telehealth versus conventional clinic-based hearing healthcare (HHC) delivery model among older adults who are existing hearing aid users to determine if a telehealth HHC model improves hearing aid use and other communication outcomes compared to clinic-based HHC.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of telehealth audiological rehabilitative service delivery for hearing loss in aging?
Is telehealth for audiology services safe for humans?
Research shows that telehealth in audiology is generally safe and effective, providing reliable results for hearing tests and treatments similar to traditional in-person methods. It has been successfully used for various services, including hearing aid verification and counseling, without significant safety concerns.13678
How does telehealth audiological rehabilitative service delivery differ from other treatments for hearing loss in aging?
Telehealth audiological rehabilitative service delivery is unique because it allows patients to receive hearing care remotely, breaking down geographic barriers and reaching underserved communities. This approach is cost-effective, quick, and can provide personalized rehabilitation, making it a promising alternative to traditional in-person audiology services.12478
Research Team
Frank R Lin, MD, PhD
Principal Investigator
Johns Hopkins University
Victoria A Sanchez, AuD, PhD
Principal Investigator
University of South Florida
Eligibility Criteria
This trial is for older adults aged 70-84 with adult-onset hearing loss who previously participated in the ACHIEVE trial. They must have a mild to moderate hearing impairment and be open to using telehealth or clinic-based hearing care. Exclusions include severe vision impairment, recent use of hearing aids, unwillingness to wear them daily, certain ear conditions, and significant disability in daily activities.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either telehealth or conventional clinic-based hearing healthcare services
Crossover
Participants in the conventional HHC arm cross-over to receive telehealth HHC
Follow-up
Participants are monitored for hearing aid use and communication outcomes
Treatment Details
Interventions
- Clinic-based audiological rehabilitative service delivery
- Telehealth audiological rehabilitative service delivery
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Wake Forest University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
University of North Carolina
Collaborator
University of South Florida
Collaborator
University of Mississippi Medical Center
Collaborator
University of Minnesota
Collaborator